Sign In

Jared Hopkins

Reporter at The Wall Street Journal

Jared S. Hopkins, a seasoned journalist, has a strong background in reporting and investigative journalism. He pursued his education at the University of Maryland, specializing in Journalism and English. Jared has worked at prestigious organizations including The Wall Street Journal, Bloomberg LP, Chicago Tribune, and the Times-News of Twin Falls, Idaho.

Highlights

May 29 · linkedin

Had to miss baby bedtime for this late night scoop with Laura Cooper: Merck is close to a $1.3 billion deal to buy EyeBio, a move that would push the big drugmaker into the large and growing market for eyecare. It would be the latest acquisition under CEO Rob Davis, who has been doing deals to lessen Merck’s reliance on Keytruda, the company’s top-selling drug, which will lose patent protection in a few years. Remember to subscribe to The Wall Street Journal for all your pharma and healthcare news.

Dec 30 · linkedin

Latest in The Wall Street Journal with Laura Cooper is about how in 2022, drugmakers like Pfizer Bristol Myers Squibb Amgen turned to acquiring biotechs with approved or drugs that finished testing to help quickly generate sales as patent expirations of to-selling products loom

Jared Hopkins
Add to my network

Location

New York, New York